Presentation EuroPCR 2024 Is coronary artery bypass surgery cost-effective compared with contemporary PCI? A FAME 3 analysis Presenter: Frederik Zimmermann May 15, 2024
News Conference News EuroPCR 2020 No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms Michael O'Riordan June 26, 2020
News Conference News EuroPCR 2018 ‘Almost Perfect’ Agreement Seen Between Angiography- and CTA-Guided Treatment Decisions in Left Main, Three-Vessel Disease Yael L. Maxwell May 22, 2018